Cargando…
Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
BACKGROUND: In patients suffering from Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) disease severity is assessed by Medical Research Counsil (MRC) Scale or Inflammatory Neuropathy Cause and Treatment (INCAT) disability score. However, none of these methods is appropriate to objectively a...
Autores principales: | Klehmet, Juliane, Beutner, Svenja, Hoffmann, Sarah, Dornauer, Matthias, Paul, Friedemann, Reilmann, Ralf, Brandt, Alexander U., Meisel, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556046/ https://www.ncbi.nlm.nih.gov/pubmed/31176377 http://dx.doi.org/10.1186/s12883-019-1339-x |
Ejemplares similares
-
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study
por: Hoffmann, Sarah, et al.
Publicado: (2015) -
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
por: Stascheit, Frauke, et al.
Publicado: (2021) -
Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
por: Diederich, Jan-Markus, et al.
Publicado: (2018) -
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2023) -
An atypical form of chronic inflammatory demyelinating polyneuropathy presenting with initial isolated bulbar weakness
por: Mansour, Malek, et al.
Publicado: (2020)